Literature DB >> 23963134

Contribution of protein Z and protein Z-dependent protease inhibitor in generalized Shwartzman reaction.

Antje Butschkau1, Philipp Nagel, Eberhard Grambow, Dietmar Zechner, George J Broze, Brigitte Vollmar.   

Abstract

OBJECTIVE: Sepsis, a leading cause of mortality in critically ill patients, is closely linked to the excessive activation of coagulation and inflammation. Protein Z, a cofactor for the protein Z-dependent protease inhibitor, enhances the inhibition of coagulation factor Xa, and protein Z-dependent protease inhibitor inhibits factor XIa in a protein Z-independent fashion. The functions of protein Z and protein Z-dependent protease inhibitor in the inflammatory and coagulant responses to septic illness have not been evaluated.
DESIGN: For induction of generalized Shwartzman reaction, dorsal skinfold chamber-equipped mice were challenged twice with lipopolysaccharide (0.05 mg/kg on day -1 and 5 mg/kg body weight 24 hr later). Time-matched control animals received equal volumes of saline.
SETTING: University research laboratory. SUBJECTS, INTERVENTIONS, AND MEASUREMENTS: Using intravital fluorescence microscopy in protein Z-dependent protease inhibitor deficient (ZPI) and protein Z deficient (PZ) mice, as well as their wild-type littermates (ZPI, PZ), kinetics of light/dye-induced thrombus formation and microhemodynamics were assessed in randomly chosen venules. Plasma concentrations of chemokine (C-X-C motif) ligand 1, interleukin-6, and interleukin-10 were measured. Liver and lung were harvested for quantitative analysis of leukocytic tissue infiltration and thrombus formation. MAIN
RESULTS: After induction of generalized Shwartzman reaction, all mice showed significant impairment of microhemodynamics, including blood flow velocity, volumetric blood flow, and functional capillary density, as well as leukocytopenia and thrombocytopenia. Thrombus formation time was markedly prolonged after induction of generalized Shwartzman reaction in all mice, except of ZPI mice, which also had a significantly higher fraction of occluded vessels in liver sections. PZ mice developed the highest concentrations of interleukin-6 and interleukin-10 in response to generalized Shwartzman reaction and showed greater leukocytic tissue infiltration than their wild-type littermates.
CONCLUSIONS: In this murine model of generalized Shwartzman reaction, protein Z-dependent protease inhibitor deficiency enhanced the thrombotic response to vascular injury, whereas protein Z deficiency increased inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23963134      PMCID: PMC3841229          DOI: 10.1097/CCM.0b013e318298a562

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  47 in total

1.  Immunosuppressants accelerate microvascular thrombus formation in vivo: role of endothelial cell activation.

Authors:  Anja Püschel; Nicole Lindenblatt; Juliane Katzfuss; Brigitte Vollmar; Ernst Klar
Journal:  Surgery       Date:  2011-10-22       Impact factor: 3.982

2.  Contributions of basic amino acids in the autolysis loop of factor XIa to serpin specificity.

Authors:  Alireza R Rezaie; Mao-fu Sun; David Gailani
Journal:  Biochemistry       Date:  2006-08-08       Impact factor: 3.162

3.  The isolation of a new warfarin-sensitive protein from bovine plasma.

Authors:  C V Prowse; M P Esnouf
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

Review 4.  Laboratory models of sepsis and septic shock.

Authors:  M P Fink; S O Heard
Journal:  J Surg Res       Date:  1990-08       Impact factor: 2.192

Review 5.  Neutrophils in development of multiple organ failure in sepsis.

Authors:  K A Brown; S D Brain; J D Pearson; J D Edgeworth; S M Lewis; D F Treacher
Journal:  Lancet       Date:  2006-07-08       Impact factor: 79.321

6.  Characterization of the protein Z-dependent protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Blood       Date:  2000-11-01       Impact factor: 22.113

7.  Frequency of protein Z deficiency in patients with ischaemic stroke.

Authors:  M Vasse; E Guegan-Massardier; J Y Borg; F Woimant; C Soria
Journal:  Lancet       Date:  2001-03-24       Impact factor: 79.321

8.  Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia.

Authors:  Johannes N Hoffmann; Brigitte Vollmar; Matthias W Laschke; Dietrich Inthorn; Jan Fertmann; Friedrich W Schildberg; Michael D Menger
Journal:  Crit Care Med       Date:  2004-04       Impact factor: 7.598

9.  Isolation of a protein Z-dependent plasma protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 10.  The microcirculation is the motor of sepsis.

Authors:  Can Ince
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

View more
  5 in total

1.  Low protein Z plasma level is a risk factor for acute myocardial infarction in coronary atherosclerosis disease patients.

Authors:  Baoxin Liu; Yong Li; Jiachen Luo; Liming Dai; Jinlong Zhao; Hongqiang Li; Qiqiang Jie; Dongzhi Wang; Xin Huang; Yidong Wei
Journal:  Thromb Res       Date:  2016-10-13       Impact factor: 3.944

2.  Protein Z-deficiency is associated with enhanced neointima formation and inflammatory response after vascular injury in mice.

Authors:  Antje Butschkau; Nana-Maria Wagner; Laura Bierhansl; Berit Genz; Brigitte Vollmar
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 3.  Experimental Models to Study Skin Wound Healing with a Focus on Angiogenesis.

Authors:  Eberhard Grambow; Heiko Sorg; Christian G G Sorg; Daniel Strüder
Journal:  Med Sci (Basel)       Date:  2021-08-25

4.  3D-printed lightweight dorsal skin fold chambers from PEEK reduce chamber-related animal distress.

Authors:  Wentao Xie; Matthias Lorenz; Friederike Poosch; Rupert Palme; Dietmar Zechner; Brigitte Vollmar; Eberhard Grambow; Daniel Strüder
Journal:  Sci Rep       Date:  2022-07-08       Impact factor: 4.996

5.  Anti-inflammatory Activity of the Protein Z-Dependent Protease Inhibitor.

Authors:  Mahita Razanakolona; Frédéric Adam; Elsa Bianchini; François Saller; Allan de Carvalho; Jean-Luc Diehl; Cécile V Denis; Ferhat Meziani; Delphine Borgel; Julie Helms; Marc Vasse
Journal:  TH Open       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.